Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma have?
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma has 34 citations in the OpenAlex counts ScholarIQ stores.
When was Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma published?
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma has 2025 year in the ScholarIQ index.
What is the open-access status of Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma?
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma has closed oa status in the ScholarIQ index.
What is the DOI of Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma?
The DOI for Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma is on the source record.
What is the PMID of Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma?
The PMID for Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma is on the source record.
What is the OpenAlex record for Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma?
The OpenAlex for Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma is on the source record.